Lack of isohemagglutinin production following minor ABO incompatible unrelated HLA mismatched umbilical cord blood transplantation

Bone Marrow Transplantation

Volumn 38, Issue 2, 2006, Pages 135-140

  Snell, M ^a   Chau, C ^a   Hendrix, D ^a   Fox, R ^a   Downes, K A ^a   Creger, R ^a   Meyerson, H ^a   Telen, M J ^b   Laughlin, M J ^a   Lazarus, H M ^a   Yomtovian, Roslyn ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ABO incompatibility; Isoagglutinins; Umbilical cord blood transplantation

Indexed keywords

BUSULFAN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; HEMAGGLUTININ; HLA ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ANEMIA; BLOOD GROUP ABO INCOMPATIBILITY; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMOLYSIS; HLA MATCHING; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REVIEW; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; BLOOD GROUP INCOMPATIBILITY; CHILD; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FOLLOW-UP STUDIES; HEMAGGLUTINATION TESTS; HEMAGGLUTININS; HEMOLYSIS; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 33745744378     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705409     Document Type: Review

References (27)

1. Worel N, Greinix HT, Keil F, Mitterbauer M, Lechner K, Fischer G et al. Severe immune hemolysis after minor ABO-mismatched allogenic peripheral blood progenitor cell transplantation occurs more frequently after nonmyelo-ablative than myeloablative conditioning. Transfusion 2002; 42: 1293-1301.
2. Rowley SD. Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs. Bone Marrow Transplant 2001; 28: 315-321.
3. Salmon JP, Michaux S, Hermanne JP. Delayed massive hemolysis mediated by minor ABO incompatibility after allogenic peripheral blood progenitor cell transplantation. Transfusion 1999; 39: 824-827.
4. Oziel S, Barbey C, Chabannon C. Early and fatal immune hemolysis after so called minor ABO incompatible peripheral blood stem cell allotransplantation. Bone Marrow Transplant 1997; 19: 1155-1156.
5. Toren A, Dacosta Y, Manny N, Varadi G, Or R, Nagler A. Passenger B-lymphocyte induced severe hemolytic disease after allogenic peripheral blood stem cell transplantation. Blood 1996; 87: 843-844.
6. Forman SJ, Blume KG, Thomas ED. Bone Marrow Transplantation. Blackwell Scientific Publications: Boston, 1994.
7. Laurencet FM, Samii K, Bressoud A, Tajeddin M, Easton J, Stelling MJ et al. Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility. Hematol Cell Ther 1997; 39: 159-162.
8. Mollison PL, Engelfriet CP, Contreras M. Blood Transfusion in Clinical Medicine, 10th edn. Blackwell Science: Oxford, 1997 pp. 79-80, 123-124.
9. Laughlin MJ, Barker J, Bambach B, Koc ON, Rizzieri DA, Wagner JE et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. New Engl J Med 2001; 344: 1815-1822.
10. Sobocinski KA, Horowitz MM, Rowlings PA, Zhang MJ, Nugent ML, Passweg JR et al. Bone Marrow Transplantation - 1994: A report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. J Hematother 1994; 3: 95-102.
11. Applebaum FR, Clift R, Buckner CD, Anasetti C, Radich J, Higano T et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia. Med Oncol 1994; 11: 69-74.
12. Copelan EA, Biggs JC, Szer J, Thompson JM, Crilley P, Brodsky I et al. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia and multiple myeloma following preparation with busulfan and cyclophosfamide (BuCy2). Semin Oncol 1993; 20 (4 Suppl 4): 33-38.
13. Blume KG, Kopecky KJ, Henslee-Downey JP, Forman SJ, Stiff PJ, LeMaistre CF et al. A prospective randomized comparison of total body irradiation-etoposide versus busulfan-cyclophosfamide as preparatory regimens for bone marrow transplantation in patients with leukemia who were not in first remission: A Southwest Oncology Group study. Blood 1993; 81: 2187-2193.
14. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
15. Flowers ME, Kansu E, Sullivan KM. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am 1999; 13: 1091-1112.
16. Laughlin MJ. Umbilical cord blood for allogencic transplantation in children and adults. Bone Marrow Transplant 2001; 27: 1-6.
17. Gajewaski JL, Petz LD, Calhoun L. Hemolysis of transfused group O red blood cells in minor ABO- incompatible unrelated donor bone marrow transplants in patients receiving cyclosporin without posttransplant methotrexate. Blood 1992; 79: 3076-3085.
18. Bolan CD, Childs RW, Procter JL, Barrett AJ, Leitman SF. Massive immune hemolysis after allogenic peripheral blood stem cell transplantation with minor ABO incompatibility. Br J Haematol 2001; 112: 787-795.
19. Ramsey G, Nusbacher J, Starzl TE, Lindsay GD. Isohemag-glutinins of graft origin after ABO-unmatched liver transplantation. New Engl J Med 1984; 311: 1167-1170.
20. Sniecinski IJ, O'Donnell MR. Hemolytic complications of hematopoietic cell transplantation. In: Thomas ED, Blume KG, Forman SJ (eds). Hematopoietic Cell Transplantation. Blackwell Science: Malden, 1999, pp. 674-684.
21. Greeno EW, Perry EH. Exchange transfusion the hard way: Massive hemolysis following transplantation of bone marrow with minor ABO incompatibility. Transfusion 1996; 36: 71-74.
22. Hows J, Beddow K, Smith E. Donor derived red blood cell antibodies and immune hemolysis after allogenic bone marrow transplantation. Blood 1986; 67: 177-181.
23. Theilgaard-Monch K, Jensen KR, Palm H. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogenic stem cell grafts. Bone Marrow Transplant 2001; 28: 1073-1082.
24. Agematsu K. Memory B cells and CD27. Histol Histopathol 2000; 15: 573-576.
25. Lee HJ, Lee HJ, Choi SJ, Kim S, Seol M, Kwon SW et al. Changes in isoagglutinin titres after ABO-incompatible allogeneic stem cell transplantation. Br J Haematol 2003; 120: 702-710.
26. Paloczi K, Batai A, Gopcsa L. Immunophenotypic characterization of cord blood B-lymphocytes. Bone Marrow Transplant 1998; 22 (Suppl. 4): S89-S91.
27. Benjamin RJ, McGurk S, Ralston MS, Churchill WH, Antin JH. ABO incompatibility as an adverse risk factor for survival after allogenic bonemarrow transplantation. Transfusion 1999; 39: 179-187.